
Value of top U.S. biotech IPOs 2022
According to the statistic, biotech company HilleVax from Massachusetts had an IPO valued at 230 million U.S. dollars. This statistic shows the leading U.S. biotech companies by value of their initial public offerings (IPOs), as reported for 2022.